Home
The Firm
About Us
Thera Team
Our Expertise
Our Services
What We Deliver
Projects
Topics
Biosimilars
Cancer
Cardiovascular-Reno-Metabolic
Complex Generics
Migraine
Mental Health
Obesity
Patient Participation
Pharmaceutical Relocation
Rare diseases
Regulatory Convergence & Harmonization
Unfair Competition
Value in Health
Women’s health
Documents
Policy papers
Columns
Biosimilars LATAM – El Economista
Cardio-Reno-Metabolic Axis – El Economista
Complex Generics – El Economista
Migraine – El Economista
Mental Health OECD 2025 – El Economista
Obesity – El Economista
Patient Paticipation in Health Decision-Making – El Economista
Pharmaceutical Relocation – El Economista
Regulatory Convergence & Harmonization – El Economista
Unfair Competition – El Economista
Value in Health – El Economista
Women’s Health Gaps – El Economista
Word Cancer Day 2026 – El Economista
World Rare Disease Day 2026 – El Economista
News
Health Policy & Systems
ALIFAR 2026
Column on Cardio-Reno-Metabolic Syndrome – El Economista, June 10th, 2026
Market Access
Column Biosimilars LATAM – El Economista, April 10th, 2026
Column Unfair Competition – El Economista, April 30th, 2026
Legal & Regulatory
Multi-Stakeholders Collaboration
Ethics & Compliance
The Cardio-Renal-Metabolic Axis: An Opportunity Health Systems Can No Longer Afford to Postpone
Adapted from the Spanish column originally published in El Economista on June 10th, 2026
by José Luis Cárdenas Tomažič / Dr. Guillermo E. Maligne
